Navigation Links
Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
Date:11/11/2008

ay significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may invent better technology; that our products may not work as well as hoped or worse, that our products may harm recipients; and that we may not be able to raise sufficient funds for development or working capital when we require it. As well, our products may never develop into useful products and even if they do, they may not be approved for sale to the public. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in our filings from time to time with the Securities and Exchange Commission ("SEC"), which we strongly urge you to read and consider, including our Registration Statement on Form S-1, as amended, that was declared effective on August 7, 2008; and our annual report on Form 10-K filed with the SEC on October 30, 2008, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth in our reports filed with the SEC. We expressly disclaim any intent or obligation to update any forward-looking statements.

For more information, please contact:

T
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
2. Raptor Pharmaceuticals Provides Update on Targeting Platforms
3. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
4. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
5. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
6. Raptor Pharmaceuticals Provides Update of Product Programs
7. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
8. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
9. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
10. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
11. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der ... Die interaktive PDF, verfügbar unter pharmaserialisation.com , ... dem sie jeweils in Kraft treten. ... Serialisierung nicht länger um das "ob", sondern darum, ...
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/19/2014)... Sept. 19, 2014  PCI is pleased to ... Biotec is a leading provider of Clinical Trial ... Bridgend, Wales in the ... significantly expands PCI,s presence in the UK/EU to ... adding packaging, storage and distribution capacity, as well ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/21/2014)... (PRWEB) September 21, 2014 The ... implements and supports electronic medical records (EMR) and ... from federal healthcare legislation during the past five ... so during the five years to 2019. The ... Health Act established Medicare and Medicaid incentives to ...
(Date:9/21/2014)... September 21, 2014 Discount-Dress.com, ... accessories, has recently announced its decision to implement a ... shopping easier for ladies across the world. Furthermore, the ... dresses for ladies. , The new items come ... with discounted prices, up to 56 percent off. "We ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 To accommodate ... e-powered platform and provide more trendy items. Recently, the ... . By offering the new and elegant wedding gowns, ... get what they need in an easy way. Its ... deeply discounted rates, from 12% off to 62% off. ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 An experienced ... released its newest hosting ranking list and announced that ... best VPS hosting suppliers. , There has been ... new demand has resulted in an increase in the ... of different services at very affordable prices. VPS (Virtual ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Developers and ... have announced a new transition plugin entitled Transpack ... 3 delivers high quality transitions that will add a ... Christina Austin, CEO of Pixel Film Studios. “Blurring the ... a definite game changer.” , Transpack Vol. 3 returns ...
Breaking Medicine News(10 mins):Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2
... CHATSWORTH, Calif., June 3 Americans are among ... news that more of us are,learning to savor ... American adults have turned to massage for pain ... American Massage,Therapy Association. Baby boomers are particular enthusiasts, ...
... RemitCycle 360(TM) business process outsourcing (BPO) solution forms core of ... ... services, DALLAS, June 3 BancTec, ... and solutions, has,signed a five-year agreement with Enterprise Bank & Trust, ...
... Everyday Language: ,A Novel Diet, by ... Nikki Lang, ... more solid, practical and realistic approach to,weight control." -- Nutritionist, Barbara Porcelli, ... Novel Diet,",published by iUniverse, Inc., which offers a unique approach to the ...
... 3 When Brett Waslefsky,s wife,said her job was ... school,teacher, the stresses of the job, as well as ... stay healthy. With this casual,conversation, a new kind of ... Vita, a web-based vitamin company,that offers occupation specific nutritional ...
... The number of bacteria living within the body of ... human cells 10 to 1. Changes in these ... diseases, gum disease and even obesity. Despite their ... residing within us remain largely unstudied and a concerted ...
... Calif., June 3 Watson,Pharmaceuticals, Inc. (NYSE: ... announced today that it has received approval ... of its Abbreviated New Drug Application,(ANDA) for ... and,10mEq strengths., Potassium-Chloride is the generic ...
Cached Medicine News:Health News:Massage Chairs Promote Comfort and Happy Dads for Father's Day 2Health News:BancTec and Enterprise Bank & Trust Partner to Deliver Revenue Cycle Management for Healthcare Providers 2Health News:BancTec and Enterprise Bank & Trust Partner to Deliver Revenue Cycle Management for Healthcare Providers 3Health News:Who Knew You Could Learn to Lose Weight by Reading an Enjoyable Novel? 2Health News:New Vitamin Company Caters to Occupational Health Concerns 2Health News:Scientist study bacterial communities inside us to better understand health and disease 2Health News:Scientist study bacterial communities inside us to better understand health and disease 3Health News:Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules 2
... The new face-lifted Leica RM2125 microtome ... Leica RM2125 and Leica RM2125 RT. All ... cover to avoid debris entering the precision ... comes with a two-step trimming function and ...
... scale heavy-duty sectioning system is the standard microtome ... a real working animal. ,Large specimens up to ... as bone or teeth and whole organs (brain, ... of accessories, specially designed for paraffin and resin ...
... Designed for biomedical and industrial applications, the ... a variety of applications in all laboratories ... to be sectioned. Its sturdy construction lends ... The safety features of the system, such ...
... The Leica SM2000 R sliding ... designed to section paraffin-embedded samples in ... can also be used for some ... is available fully equipped to meet ...
Medicine Products: